Webb21 sep. 2024 · Recro ( NASD: REPH) is a bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New … Webb21 mars 2024 · SAN DIEGO and GAINESVILLE, Ga., March 21, 2024 (GLOBE NEWSWIRE) — Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and …
Recro Pharma : ANNOUNCES NAME CHANGE TO SOCIETAL …
Webb23 aug. 2024 · Recro Pharma Inc. published this content on 23 August 2024 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 23 August 2024 13:23:06 UTC . WebbFrom 2008 to December 2024, Ms. Henwood was the President, Chief Executive Officer and a director of Recro Pharma, Inc. (REPH), a company she founded in 2008. From 2006 to 2013, Ms. Henwood served as the President of Malvern Consulting Group, Inc., or MCG, a pharmaceutical incubator and consulting firm. new clear world yugioh
Societal CDMO (SCTL)
Webb13 apr. 2024 · Recro Pharma's mailing address is 490 LAPP ROAD, MALVERN PA, 19355. The official website for the company is www.recropharma.com . The specialty … WebbThe RECOPHARMA Project was born with the purpose of designing, developing, validating and demonstrating an effective treatment to recover the Recalcitrant Cytostatic Drugs … Webb27 mars 2024 · Recro Pharma, Inc. (NASDAQ:REPH) issued its quarterly earnings results on Tuesday, March, 1st. The specialty pharmaceutical company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.03. Recro Pharma had a negative net margin of 15.15% and a negative trailing twelve-month return … new clear vision